Pathogenesis of insulin resistance in skeletal muscle

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Abdul Ghani, Muhammad A ^a   Defronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD36 ANTIGEN; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; LONG CHAIN FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE;

CELL FUNCTION; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FATTY ACID METABOLISM; GLUCONEOGENESIS; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HEREDITY; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHOSPHORYLATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL;

EID: 77952503211     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/476279     Document Type: Review

References (234)

1. DeFronzo R. A., Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes Diabetes Reviews 1997 5 3 177 269
2. DeFronzo R. A., The triumvirate:-cell, muscle, liver. A collusion responsible for NIDDM Diabetes 1988 37 6 667 687
3. DeFronzo R. A., Pathogenesis of type 2 diabetes mellitus Medical Clinics of North America 2004 88 4 787 835
4. Defronzo R. A., From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 2009 58 4 773 795
5. DeFronzo R. A., Gunnarsson R., Bjorkman O., Olsson M., Wahren J., Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus The Journal of Clinical Investigation 1985 76 1 149 155
6. Mitrakou A., Kelley D., Veneman T., Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM Diabetes 1990 39 11 1381 1390
7. Cusi K., Maezono K., Osman A., Insulin resistance differentially affects the PI 3-kinase-and MAP kinase-mediated signaling in human muscle The Journal of Clinical Investigation 2000 105 3 311 320
8. Bajaj M., DeFronzo R. A., Metabolic and molecular basis of insulin resistance Journal of Nuclear Cardiology 2003 10 3 311 323
9. Bouzakri K., Koistinen H. A., Zierath J. R., Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes Current Diabetes Reviews 2005 1 2 167 174
10. Karlsson H. K. R., Zierath J. R., Insulin signaling and glucose transport in insulin resistant human skeletal muscle Cell Biochemistry and Biophysics 2007 48 2-3 103 113
11. Lettner A., Roden M., Ectopic fat and insulin resistance Current Diabetes Reports 2008 8 3 185 191
12. McGarry J. D., Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 2002 51 1 7 18
13. Petersen K. F., Shulman G. I., Etiology of insulin resistance American Journal of Medicine 2006 119 5, supplement 1 10S 16S
14. Bays H., Mandarino L., DeFronzo R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach Journal of Clinical Endocrinology and Metabolism 2004 89 2 463 478
15. Krssak M., Roden M., The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans Reviews in Endocrine and Metabolic Disorders 2004 5 2 127 134
16. Roden M., Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes International Journal of Obesity 2005 29 supplement 2 S111 S115
17. Morino K., Petersen K. F., Shulman G. I., Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Diabetes 2006 55 supplement 2 S9 S15
18. Abdul-Ghani M. A., DeFronzo R. A., Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus Current Diabetes Reports 2008 8 3 173 178
19. Hjlund K., Mogensen M., Sahlin K., Beck-Nielsen H., Mitochondrial dysfunction in type 2 diabetes and obesity Endocrinology and Metabolism Clinics of North America 2008 37 3 713 731
20. Lowell B. B., Shulman G. I., Mitochondrial dysfunction and type 2 diabetes Science 2005 307 5708 384 387
21. Groop L. C., Bonadonna R. C., DelPrato S., Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance The Journal of Clinical Investigation 1989 84 1 205 213
22. Blaak E. E., Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance Best Practice and Research: Clinical Endocrinology and Metabolism 2005 19 3 391 403
23. Kiens B., Skeletal muscle lipid metabolism in exercise and insulin resistance Physiological Reviews 2006 86 1 205 243
24. Thiebaud D., Jacot E., DeFronzo R. A., Maeder E., Jequier E., Felber J. P., The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man Diabetes 1982 31 11 957 963 (Pubitemid 12005566)
25. Himsworth H. P., Kerr R. B., Insulin-sensitive and insulin-insensitive types of diabetes mellitus Clinical Science 1939 4 120 152
26. Ginsberg H., Kimmerling G., Olefsky J. M., Reaven G. M., Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia The Journal of Clinical Investigation 1975 55 3 454 461
27. DeFronzo R. A., Deibert D., Hendler R., Felig P., Soman V., Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes The Journal of Clinical Investigation 1979 63 5 939 946 (Pubitemid 9182544)
28. DeFronzo R. A., Soman V., Sherwin R. S., Hendler R., Felig P., Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding The Journal of Clinical Investigation 1978 62 1 204 213
29. Butterfield W. J. H., Whichelow M. J., Peripheral glucose metabolism in control subjects and diabetic patients during glucose, glucose-insulin and insulin sensitivity tests Diabetologia 1965 1 1 43 53
30. Kashyap S. R., Belfort R., Berria R., Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes American Journal of Physiology 2004 287 3 E537 E546
31. Danadian K., Balasekaran G., Lewy V., Meza M. P., Robertson R., Arslanian S. A., Insulin sensitivity in African-American children with and without family history of type 2 diabetes Diabetes Care 1999 22 8 1325 1329
32. Petersen K. F., Dufour S., Befroy D., Garcia R., Shulman G. I., Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes The New England Journal of Medicine 2004 350 7 664 671
33. Kahn S. E., Hull R. L., Utzschneider K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 2006 444 7121 840 846 213
34. Bogardus C., Lillioja S., Mott D., Reaven G. R., Kashiwagi A., Foley J. E., Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians The Journal of Clinical Investigation 1984 73 3 800 805
35. Ferrannini E., Buzzigoli G., Bonadonna R., Insulin resistance in essential hypertension The New England Journal of Medicine 1987 317 6 350 357
36. Bressler P., Bailey S. R., Matsuda M., DeFronzo R. A., Insulin resistance and coronary artery disease Diabetologia 1996 39 11 1345 1350
37. DeFronzo R. A., Glucose intolerance and aging. Evidence for tissue insensitivity to insulin Diabetes 1979 28 12 1095 1101
38. Lankarani M., Valizadeh N., Heshmat R., Peimani M., Sohrabvand F., Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome Gynecological Endocrinology 2009 25 8 504 507
39. Bailey J. L., Zheng B., Hu Z., Price S. R., Mitch W. E., Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy Journal of the American Society of Nephrology 2006 17 5 1388 1394
40. Swan J. W., Anker S. D., Walton C., Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure Journal of the American College of Cardiology 1997 30 2 527 532
41. Livingston J. N., Moxley R. T. III, Myotonic dystrophyphenotype-genotype and insulin resistance Diabetes Reviews 1994 2 1 29 42
42. Simha V., Garg A., Lipodystrophy: lessons in lipid and energy metabolism Current Opinion in Lipidology 2006 17 2 162 169
43. Van Cromphaut S. J., Vanhorebeek I., Van den Berghe G., Glucose metabolism and insulin resistance in sepsis Current Pharmaceutical Design 2008 14 19 1887 1899
44. Pagano G., Cavallo-Perin P., Cassader M., An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects The Journal of Clinical Investigation 1983 72 5 1814 1820
45. Hruz P. W., HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models Current Opinion in HIV and AIDS 2008 3 6 660 665
46. Jacob S., Rett K., Wicklmayr M., Agrawal B., Augustin H. J., Dietze G.-J., Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study Journal of Hypertension 1996 14 4 489 494
47. Jani R., Molina M., Matsuda M., Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range Diabetes Care 2008 31 2 311 315
48. DeFronzo R. A., Insulin secretion, insulin resistance, and obesity International Journal of Obesity 1982 6 supplement 1 73 82
49. Lemay A., Turcot L., Dchne F., Dodin S., Forest J. C., Hyperinsulinemia in nonobese women reporting a moderate weight gain at the beginning of menopause: a useful early measure of susceptibility to insulin resistance Menopause 2010 17 2 321 325
50. Wedick N. M., Snijder M. B., Dekker J. M., Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the hoorn study Obesity 2009 17 8 1609 1614
51. Erdmann J., Kallabis B., Oppel U., Sypchenko O., Wagenpfeil S., Schusdziarra V., Development of hyperinsulinemia and insulin resistance during the early stage of weight gain American Journal of Physiology 2008 294 3 E568 E575
52. Schrauwen P., High-fat diet, muscular lipotoxicity and insulin resistance Proceedings of the Nutrition Society 2007 66 1 33 41
53. Pan D. A., Lillioja S., Kriketos A. D., Skeletal muscle triglyceride levels are inversely related to insulin action Diabetes 1997 46 6 983 988
54. Phillips D. I. W., Caddy S., Ilic V., Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects Metabolism 1996 45 8 947 950
55. Perseghin G., Scifo P., De Cobelli F., Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents Diabetes 1999 48 8 1600 1606
56. Krssak M., Falk Petersen K., Dresner A., Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study Diabetologia 1999 42 1 113 116
57. Reaven G. M., Role of insulin resistance in human disease Diabetes 1988 37 12 1595 1607
58. Mokdad A. H., Ford E. S., Bowman B. A., Diabetes trends in the U.S.: 1990-1998 Diabetes Care 2000 23 9 1278 1283
59. Groop L. C., Saloranta C., Shank M., Bonadonna R. C., Ferrannini E., DeFronzo R. A., The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism 1991 72 1 96 107
60. Reaven G. M., Hollenbeck C., Jeng C.-Y., Wu M. S., Chen Y.-D. I., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM Diabetes 1988 37 8 1020 1024
61. Perseghin G., Ghosh S., Gerow K., Shulman G. I., Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study Diabetes 1997 46 6 1001 1009
62. Griffin M. E., Marcucci M. J., Cline G. W., Free fatty acid-induced insulin resistance is associated with activation of protein kinase C and alterations in the insulin signaling cascade Diabetes 2000 48 6 1270 1274
63. Dresner A., Laurent D., Marcucci M., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity The Journal of Clinical Investigation 1999 103 2 253 259
64. Yu C., Chen Y., Cline G. W., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle The Journal of Biological Chemistry 2002 277 52 50230 50236
65. Belfort R., Mandarino L., Kashyap S., Dose-response effect of elevated plasma free fatty acid on insulin signaling Diabetes 2005 54 6 1640 1648
66. Itani S. I., Ruderman N. B., Schmieder F., Boden G., Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I B-Diabetes 2002 51 7 2005 2011
67. Richardson D. K., Kashyap S., Bajaj M., Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle The Journal of Biological Chemistry 2005 280 11 10290 10297
68. Boden G., Chen X., Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes The Journal of Clinical Investigation 1995 96 3 1261 1268
69. Bajaj M., Suraamornkul S., Romanelli A., Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients Diabetes 2005 54 11 3148 3153
70. Bajaj M., Suraamornkul S., Kashyap S., Cusi K., Mandarino L., DeFronzo R. A., Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes Journal of Clinical Endocrinology and Metabolism 2004 89 9 4649 4655
71. Vaag A., Skott P., Damsbo P., Gall M.-A., Richter E. A., Beck-Nielsen H., Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1991 88 4 1282 1290
72. Santomauro A. T. M. G., Boden G., Silva M. E. R., Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects Diabetes 1999 48 9 1836 1841
73. Unger R. H., Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications Diabetes 1995 44 8 863 870
74. Boden G., Lebed B., Schatz M., Homko C., Lemieux S., Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects Diabetes 2001 50 7 1612 1617
75. Storlien L. H., Jenkins A. B., Chisholm D. J., Pascoe W. S., Khouri S., Kraegen E. W., Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and-3 fatty acids in muscle phospholipid Diabetes 1991 40 2 280 289
76. Pagliassotti M. J., Pan D., Prach P., Koppenhafer T., Storlien L., Hill J. O., Tissue oxidative capacity, fuel stores and skeletal muscle fatty acid composition in obesity-prone and obesity-resistant rats Obesity Research 1995 3 5 459 464
77. Yamauchi T., Kamon J., Waki H., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine 2001 7 8 941 946
78. Kim J. K., Fillmore J. J., Chen Y., Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7522 7527
79. Greco A. V., Mingrone G., Giancaterini A., Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion Diabetes 2002 51 1 144 151
80. DeFronzo R. A., Ferrannini E., Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 1991 14 3 173 194
81. DeFronzo R. A., Insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Current Opinion in Cardiology 1990 5 5 586 593
82. Abumrad N., Coburn C., Ibrahimi A., Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm Biochimica et Biophysica Acta 1999 1441 1 4 13
83. Bonen A., Benton C. R., Campbell S. E., Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes Acta Physiologica Scandinavica 2003 178 4 347 356
84. Pownall H. J., Hamilton J. A., Energy translocation across cell membranes and membrane models Acta Physiologica Scandinavica 2003 178 4 357 365
85. Hagenfeldt L., Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man Diabetes 1979 28 supplement 1 66 70
86. Hagenfeldt L., Wahren J., Human forearm muscle metabolism during exercise. II. Uptake, release and oxidation of individual FFA and glycerol Scandinavian Journal of Clinical and Laboratory Investigation 1968 21 3 263 276
87. Havel R. J., Ekelund L. G., Holmgren A., Kinetic analysis of the oxidation of palmitate-1-14C in man during prolonged heavy muscular exercise Journal of Lipid Research 1967 8 4 366 373
88. Kiens B., Essen-Gustavsson B., Christensen N. J., Saltin B., Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training Journal of Physiology 1993 469 459 478
89. Gargiulo C. E., Stunlsatz-Krouper S. M., Schaffer J. E., Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane Journal of Lipid Research 1999 40 5 881 892
90. Ibrahimi A., Bonen A., Blinn W. D., Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin The Journal of Biological Chemistry 1999 274 38 26761 26766
91. Febbraio M., Abumrad N. A., Hajjar D. P., A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism The Journal of Biological Chemistry 1999 274 27 19055 19062
92. Luiken J. J. F. P., Arumugam Y., Dyck D. J., Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats The Journal of Biological Chemistry 2001 276 44 40567 40573
93. Steinberg G. R., Dyck D. J., Calles-Escandon J., Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle The Journal of Biological Chemistry 2002 277 11 8854 8860
94. Cameron-Smith D., Burke L. M., Angus D. J., A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle American Journal of Clinical Nutrition 2003 77 2 313 318
95. Roepstorff C., Helge J. W., Vistisen B., Kiens B., Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle Proceedings of the Nutrition Society 2004 63 2 239 244
96. Bonen A., Parolin M. L., Steinberg G. R., Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport increased sarcolemmal FAT/CD36 FASEB Journal 2004 18 10 1144 1146
97. Kiens B., Roemen T. H. M., Van der Vusse G. J., Muscular long-chain fatty acid content during graded exercise in humans American Journal of Physiology 1999 276 2 E352 E357
98. Roepstorff C., Vistisen B., Roepstorff K., Kiens B., Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise American Journal of Physiology 2004 287 4 E696 E705
99. Jain S. S., Chabowski A., Snook L. A., Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6 FEBS Letters 2009 583 13 2294 2300
100. Kelley D. E., Goodpaster B., Wing R. R., Simoneau J.-A., Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss American Journal of Physiology 1999 277 6 E1130 E1141
101. Hulver M. W., Berggren J. R., Cortright R. N., Skeletal muscle lipid metabolism with obesity American Journal of Physiology 2003 284 4 E741 E747
102. Steinberg G. R., Parolin M. L., Heigenhauser G. J. F., Dyck D. J., Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance American Journal of Physiology 2002 283 1 E187 E192
103. Turcotte L. P., Swenberger J. R., Tucker M. Z., Yee A. J., Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats Diabetes 2001 50 6 1389 1396
104. Befroy D. E., Petersen K. F., Dufour S., Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients Diabetes 2007 56 5 1376 1381
105. Szendroedi J., Schmid A. I., Chmelik M., Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes PLoS Medicine 2007 4 5, article e154
106. Petersen K. F., Dufour S., Shulman G. I., Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents PLoS Medicine 2005 2 9, article e233
107. Scheuermann-Freestone M., Madsen P. L., Manners D., Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes Circulation 2003 107 24 3040 3046
108. Schrauwen-Hinderling V. B., Kooi M. E., Hesselink M. K. C., Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects Diabetologia 2007 50 1 113 120
109. Petersen K. F., Befroy D., Dufour S., Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 2003 300 5622 1140 1142
110. Brehm A., Krssak M., Schmid A. I., Nowotny P., Waldhusl W., Roden M., Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle Diabetes 2006 55 1 136 140
111. Morino K., Petersen K. F., Dufour S., Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents The Journal of Clinical Investigation 2005 115 12 3587 3593
112. Ritov V. B., Menshikova E. V., He J., Ferrell R. E., Goodpaster B. H., Kelley D. E., Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes Diabetes 2005 54 1 8 14
113. Patti M. E., Butte A. J., Crunkhorn S., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471
114. Rolo A. P., Palmeira C. M., Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress Toxicology and Applied Pharmacology 2006 212 2 167 178
115. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunse R., Dela F., Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle Diabetologia 2007 50 4 790 796
116. Asmann Y. W., Stump C. S., Short K. R., Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia Diabetes 2006 55 12 3309 3319
117. Chavez-Velazquez A., Jani R., Abdul-Ghani M. A., Short-Term Elevation of plasma free fatty acids (FFA) decreases skeletal muscle mitochondrial membrane motential in healthy glucose tolerant subjects Diabetes 2007 56 supplement 1
118. Kelley D. E., He J., Menshikova E. V., Ritov V. B., Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 2002 51 10 2944 2950
119. Toledo F. G. S., Watkins S., Kelley D. E., Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women Journal of Clinical Endocrinology and Metabolism 2006 91 8 3224 3227
120. Abdul-Ghani M. A., Jani R., Molina M., Chavez A., Tripathy D., DeFronzo R. A., Decreased mitochondrial ATP synthesis in obese non-diabetic subjects Diabetes 2008 56 supplement 1
121. Phielix E., Schrauwen-Hinderling V. B., Mensink M., Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients Diabetes 2008 57 11 2943 2949
122. Mogensen M., Sahlin K., Fernstrm M., Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 2007 56 6 1592 1599
123. Goodpaster B. H., Katsiaras A., Kelley D. E., Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity Diabetes 2003 52 9 2191 2197
124. Greco A. V., Mingrone G., Giancaterini A., Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion Diabetes 2002 51 1 144 151
125. Jubrias S. A., Esselman P. C., Price L. B., Cress M. E., Conley K. E., Large energetic adaptations of elderly muscle to resistance and endurance training Journal of Applied Physiology 2001 90 5 1663 1670
126. Holloszy J. O., Coyle E. F., Adaptations of skeletal muscle to endurance exercise and their metabolic consequences Journal of Applied Physiology Respiratory Environmental and Exercise Physiology 1984 56 4 831 838
127. Chilibeck P. D., Syrotuik D. G., Bell G. J., The effect of concurrent endurance and strength training on quantitative estimates of subsarcolemmal and intermyofibrillar mitochondria International Journal of Sports Medicine 2002 23 1 33 39
128. stergrd T., Andersen J. L., Nyholm B., Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients American Journal of Physiology 2006 290 5 E998 E1005
129. Menshikova E. V., Ritov V. B., Toledo F. G. S., Ferrell R. E., Goodpaster B. H., Kelley D. E., Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity American Journal of Physiology 2005 288 4 E818 E825
130. Short K. R., Vittone J. L., Bigelow M. L., Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity Diabetes 2003 52 8 1888 1896
131. Chavez A. O., Kamath S., Jani R., Effect of short-term free fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals The Journal of Clinical Endocrinology Metabolism 2010 95 1 422 429
132. Abdul-Ghani M. A., Muller F., Liu Y., Deleterious effect of elevated fatty acid metabolites concentration on skeletal muscle mitochondrial ATP synthesis Diabetes 2007 56 supplement 1
133. Benton C. R., Nickerson J. G., Lally J., Modest PGC-1 overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria The Journal of Biological Chemistry 2008 283 7 4228 4240
134. Lagouge M., Argmann C., Gerhart-Hines Z., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 Cell 2006 127 6 1109 1122
135. Lim J. H., Lee J. I., Suh Y. H., Kim W., Song J. H., Jung M. H., Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells Diabetologia 2006 49 8 1924 1936
136. Brown A. E., Elstner M., Yeaman S. J., Turnbull D. M., Walker M., Does impaired mitochondrial function affect insulin signaling and action in cultured human skeletal muscle cells? American Journal of Physiology 2008 294 1 E97 E102
137. Pospisilik J. A., Knauf C., Joza N., Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes Cell 2007 131 3 476 491
138. Saltiel A. R., Kahn C. R., Insulin signalling and the regulation of glucose and lipid metabolism Nature 2001 414 6865 799 806
139. Pessin J. E., Saltiel A. R., Signaling pathways in insulin action: molecular targets of insulin resistance The Journal of Clinical Investigation 2000 106 2 165 169
140. Whitehead J. P., Clark S. F., Urs B., James D. E., Signalling through the insulin receptor Current Opinion in Cell Biology 2000 12 2 222 228
141. Ellis L., Clauser E., Morgan D. O., Edery M., Roth R. A., Rutter W. J., Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose Cell 1986 45 5 721 732
142. Chou C. K., Dull T. J., Russell D. S., Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin The Journal of Biological Chemistry 1987 262 4 1842 1847
143. Virkamki A., Ueki K., Kahn C. R., Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance The Journal of Clinical Investigation 1999 103 7 931 943
144. Sun X. J., Miralpeix M., Myers M. G. Jr., Expression and function of IRS-1 in insulin signal transmission Journal of Biological Chemistry 1992 267 31 22662 22672
145. Cross D., Alessi D., Vandenheed J., McDowell H., Hundal H., Cohen P., The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin but not rapamycin Biochemical Journal 1994 267 303 321
146. Osawa H., Sutherland C., Robey R. B., Printz R. L., Granner D. K., Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin The Journal of Biological Chemistry 1996 271 28 16690 16694
147. Lazar D. F., Wiese R. J., Brady M. J., Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin The Journal of Biological Chemistry 1995 270 35 20801 20807
148. Dent P., Lavoinne A., Nakielny S., Caudwell F. B., Watt P., Cohen P., The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle Nature 1990 348 6299 302 308
149. Newgard C. B., Brady M. J., O'Doherty R. M., Saltiel A. R., Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1 Diabetes 2000 49 12 1967 1977
150. Shepherd P. R., Nave B. T., Siddle K., Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-56 kinase Biochemical Journal 1995 305 1 25 28
151. Freidenberg G. R., Henry R. R., Klein H. H., Reichart D. R., Olefsky J. M., Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects Journal of Clinical Investigation 1987 79 1 240 250
152. Caro J. F., Sinha M. K., Raju S. M., Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes The Journal of Clinical Investigation 1987 79 5 1330 1337
153. Caro J. F., Ittoop O., Pories W. J., Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity The Journal of Clinical Investigation 1986 78 1 249 258
154. Trischitta V., Brunetti A., Chiavetta A., Benzi L., Papa V., Vigneri R., Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients Diabetes 1989 38 12 1579 1584
155. Klein H. H., Vestergaard H., Kotzke G., Pedersen O., Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM Diabetes 1995 44 11 1310 1317
156. Kashiwagi A., Verso M. A., Andrews J., In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus The Journal of Clinical Investigation 1983 72 4 1246 1254
157. Lonnroth P., Digirolamo M., Krotkiewski M., Smith U., Insulin binding and responsiveness in fat cells from patients with reduced glucose tolerance and type II diabetes Diabetes 1983 32 8 748 754
158. Olefsky J. M., Reaven G. M., Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity Diabetes 1977 26 7 680 688
159. Moller D. E., Yokota A., Flier J. S., Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM Diabetes 1989 38 11 1496 1500
160. Kusari J., Verma U. S., Buse J. B., Henry R. R., Olefsky J. M., Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1991 88 4 1323 1330
161. Nolan J. J., Freidenberg G., Henry R., Reichart D., Olefsky J. M., Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity Journal of Clinical Endocrinology and Metabolism 1994 78 2 471 477
162. Freidenberg G. R., Reichart D., Olefsky J. M., Henry R. R., Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin- dependent diabetes mellitus. Effect of weight loss The Journal of Clinical Investigation 1988 82 4 1398 1406
163. Kellerer M., Kroder G., Tippmer S., Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts Diabetes 1994 43 3 447 453
164. Pratipanawatr W., Pratipanawatr T., Cusi K., Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation Diabetes 2001 50 712 2572 2578 (Pubitemid 33642776)
165. Krook A., Bjrnholm M., Galuska D., Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients Diabetes 2000 49 2 284 292
166. Kim Y.-B., Nikoulina S. E., Ciaraldi T. P., Henry R. R., Kahn B. B., Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes The Journal of Clinical Investigation 1999 104 6 733 741
167. Andreelli F., Laville M., Ducluzeau P.-H., Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients Diabetologia 1999 42 3 358 364
168. Folli F., Saad M. J. A., Backer J. M., Kahn C. R., Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus The Journal of Clinical Investigation 1993 92 4 1787 1794
169. Morino K., Neschen S., Bilz S., Muscle-pecific IRS-1 ser→ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle Diabetes 2008 57 10 2644 2651
170. Hitman G. A., Hawrami K., McCarthy M. I., Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease Diabetologia 1995 38 4 481 486
171. Dresner A., Laurent D., Marcucci M., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity The Journal of Clinical Investigation 1999 103 2 253 259
172. Khan W. A., Blobe G. C., Hannun Y. A., Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C Cellular Signalling 1995 7 3 171 184
173. Yu C., Chen Y., Cline G. W., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle The Journal of Biological Chemistry 2002 277 52 50230 50236
174. Schmitz-Peiffer C., Browne C. L., Oakes N. D., Alterations in the expression and cellular localization of protein kinase C isozymes and are associated with insulin resistance in skeletal muscle of the high-fat-fed rat Diabetes 1997 46 2 169 178
175. Schmitz-Peiffer C., Oakes N. D., Browne C. L., Kraegen E. W., Biden T. J., Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653 American Journal of Physiology 1997 273 5 E915 E921
176. Lam T. K., Yoshii H., Haber C. A., Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta Am J Physiol Endocrinol Metab 2002 283 4 E682 91
177. Tanti J.-F., Jager J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation Current Opinion in Pharmacology 2009 9 6 753 762
178. Sell H., Eckel J., Dietze-Schroeder D., Pathways leading to muscle insulin resistancethe muscle-fat connection Archives of Physiology and Biochemistry 2006 112 2 105 113
179. Hsueh W. A., Law R. E., Insulin signaling in the arterial wall American Journal of Cardiology 1999 84 1 A 21J 24J
180. Jiang Z. Y., Lin Y.-W., Clemont A., Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats The Journal of Clinical Investigation 1999 104 4 447 457
181. Shepherd P. R., Kahn B. B., Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus The New England Journal of Medicine 1999 341 4 248 257
182. Hunter S. J., Garvey W. T., Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system American Journal of Medicine 1998 105 4 331 345
183. Bell G. I., Kayano T., Buse J. B., Molecular biology of mammalian glucose transporters Diabetes Care 1990 13 3 198 208
184. Joost H.-G., Bell G. I., Best J. D., Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators American Journal of Physiology 2002 282 4 E974 E976
185. Stuart C. A., Howell M. E. A., Zhang Y., Yin D., Insulin-stimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle Journal of Clinical Endocrinology and Metabolism 2009 94 9 3535 3542
186. Rogers P. A., Fisher R. A., Harris H., An electrophoretic study of the distribution and properties of human hexokinases Biochemical Genetics 1975 13 11-12 857 866
187. Garvey W. T., Huecksteadt T. P., Matthaei S., Olefsky J. M., Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1988 81 5 1528 1536
188. Zierath J. R., He L., Gum A., Odegaard Wahlstrm E., Klip A., Wallberg-Henriksson H., Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM Diabetologia 1996 39 10 1180 1189
189. Krook A., Bjrnholm M., Galuska D., Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients Diabetes 2000 49 2 284 292
190. Pedersen O., Bak J. F., Andersen P. H., Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity for NIDDM Diabetes 1990 39 7 865 870
191. Eriksson J., Koranyi L., Bourey R., Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle Diabetologia 1992 35 2 143 147
192. Bonadonna R. C., Del Prato S., Saccomani M. P., Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes The Journal of Clinical Investigation 1993 92 1 486 494
193. Bonadonna R. C., Del Prato S., Bonora E., Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM Diabetes 1996 45 supplement 3 915 925
194. Cline G. W., Petersen K. F., Krssak M., Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes The New England Journal of Medicine 1999 341 4 240 246
195. Williams K. V., Price J. C., Kelley D. E., Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance. A dose-response assessment using positron emission tomography Diabetes 2001 50 9 2069 2079
196. Choi W.-H., O'Rahilly S., Buse J. B., Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects Diabetes 1991 40 12 1712 1718
197. Perriott L. M., Kono T., Whitesell R. R., Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps American Journal of Physiology 2001 281 1 E72 E80
198. Printz R. L., Ardehali H., Koch S., Granner D. K., Human hexokinase II mRNA and gene structure Diabetes 1995 44 3 290 294
199. Vogt C., Ardehali H., Iozzo P., Regulation of hexokinase II expression in human skeletal muscle in vivo Metabolism 2000 49 6 814 818
200. Pendergrass M., Koval J., Vogt C., Insulin-induced hexokinase II expression is reduced in obesity and NIDDM Diabetes 1998 47 3 387 394
201. Mandarino L. J., Printz R. L., Cusi K. A., Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle American Journal of Physiology 1995 269 4 E701 E708
202. Ducluzeau P.-H., Perretti N., Laville M., Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes Diabetes 2001 50 5 1134 1142
203. Lehto M., Huang X., Davis E. M., Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity Diabetologia 1995 38 12 1466 1474
204. Laakso M., Malkki M., Kekalainen P., Kuusisto J., Deeb S. S., Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance Diabetologia 1995 38 5 617 622
205. Echwald S. M., Bjorbaek C., Hansen T., Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity Diabetes 1995 44 3 347 353
206. Gulli G., Ferrannini E., Stern M., Haffner S., DeFronzo R. A., The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents Diabetes 1992 41 12 1575 1586
207. Golay A., DeFronzo R. A., Ferrannini E., Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients Diabetologia 1988 31 8 585 591
208. Lillioja S., Mott D. M., Zawadzki J. K., Young A. A., Abbott W. G., Bogardus C., Glucose storage is a major determinant of in vivo insulin resistance in subjects with normal glucose tolerance Journal of Clinical Endocrinology and Metabolism 1986 62 5 922 927
209. Shulman G. I., Rothman D. L., Jue T., Stein P., DeFronzo R. A., Shulman R. G., Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy The New England Journal of Medicine 1990 322 4 223 228
210. Rothman D. L., Magnusson I., Cline G., Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus Proceedings of the National Academy of Sciences of the United States of America 1995 92 4 983 987
211. Vaag A., Henriksen J. E., Madsbad S., Holm N., Beck-Nielsen H., Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1995 95 2 690 698
212. Yki-Jarvinen H., Mott D., Young A. A., Stone K., Bogardus C., Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle The Journal of Clinical Investigation 1987 80 1 95 100
213. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery Biochemical Journal 2001 359, part 1 1 16
214. Cohen P., The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction Philosophical Transactions of the Royal Society B 1999 354 1382 485 495
215. Damsbo P., Vaag A., Hother-Nielsen O., Beck-Nielsen H., Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 1991 34 4 239 245
216. Mandarino L. J., Wright K. S., Verity L. S., Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase: evidence for their role in oxidative and nonoxidative glucose metabolism The Journal of Clinical Investigation 1987 80 3 655 663
217. Thorburn A. W., Gumbiner B., Bulacan F., Wallace P., Henry R. R., Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake The Journal of Clinical Investigation 1990 85 2 522 529
218. Vaag A., Henriksen J. E., Beck-Nielsen H., Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1992 89 3 782 788
219. Nyomba B. L., Freymond D., Raz I., Stone K., Mott D. M., Bogardus C., Skeletal muscle glycogen synthase activity in subjects with non-insulin- dependent diabetes mellitus after glyburide therapy Metabolism 1990 39 11 1204 1210
220. Pratipanawatr T., Cusi K., Ngo P., Pratipanawatr W., Mandarine L. J., DeFronzo R. A., Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes Diabetes 2002 51 2 462 468
221. Vestergaard H., Lund S., Larsen F. S., Bjerrum O. J., Pedersen O., Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1993 91 6 2342 2350
222. Vestergaard H., Bjorbaek C., Andersen P. H., Bak J. F., Pedersen O., Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients Diabetes 1991 40 12 1740 1745
223. Majer M., Mott D. M., Mochizuki H., Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians Diabetologia 1996 39 3 314 321
224. Orho M., Nikula-Ijas P., Schalin-Jantti C., Permutt M. A., Groop L. C., Isolation and characterization of the human muscle glycogen synthase gene Diabetes 1995 44 9 1099 1105
225. Bjrbk C., Echwald S. M., Hubricht P., Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM Diabetes 1994 43 8 976 983
226. Bjrbk C., Vik T. A., Echwald S. M., Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients Diabetes 1995 44 1 90 97
227. Prochazka M., Mochizuki H., Baier L. J., Cohen P. T. W., Bogardus C., Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin a resistance in Pima Indians Diabetologia 1995 38 4 461 466
228. Schalin-Jantti C., Harkonen M., Groop L. C., Impaired activation of glycogen synthase in people at increased risk for developing NIDDM Diabetes 1992 41 5 598 604
229. Del Prato S., Bonadonna R. C., Bonora E., Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus The Journal of Clinical Investigation 1993 91 2 484 494
230. Falholt K., Jensen I., Lindkaer Jensen S., Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients Diabetic Medicine 1988 5 1 27 31
231. Mandarino L. J., Madar Z., Kolterman O. G., Bell J. M., Olefsky J. M., Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects American Journal of Physiology 1986 251 4 E489 E496
232. Kelley D. E., Mokan M., Mandarino L. J., Intracellular defects in glucose metabolism in obese patients with NIDDM Diabetes 1992 41 6 698 706
233. Groop L. C., Bonadonna R. C., Simonson D. C., Petrides A. S., Shank M., DeFronzo R. A., Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity American Journal of Physiology 1992 263 1 E79 E84
234. Randle P. J., Garland P. B., Hales C. N., Newsholme E. A., The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus The Lancet 1963 281 7285 785 789